Emily Rogalski, PhD

  • Rosalind Franklin PhD Professor of Neurology
  • Research and Scholarly Interests: Aging Well, Aging, Healthy, Alzheimer Dementia, Alzheimer Disease, Behavoiral intervention, Caregiver, Cognitive Functions, Communication, Partner, Community Health, Frontotemporal Dementia, Magnetic Resonance Imaging, Neurology, Neuropsychology, Neuroscience, Positron Emission Tomography, Primary Progressive Aphasia, Randomized Controlled Trial, Social Work, Speech Language Pathology, SuperAging
  • Websites: Healthy Aging & Alzheimer's Research Care Center, Research Network Profile
  • Contact: erogalski@uchicago.edu
  • Graduate Program: PhD Program in Neurobiology

Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy.
Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy. Alzheimers Dement. 2025 Jan; 21(1):e14202.
PMID: 39807681

Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS.
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS. Alzheimers Dement. 2024 Dec 23.
PMID: 39713873

Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI. Alzheimers Dement. 2025 Jan; 21(1):e14218.
PMID: 39711228

Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia.
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia. Alzheimers Dement. 2024 Dec 23.
PMID: 39713899

Atypical Presentations of Alzheimer Disease.
Atypical Presentations of Alzheimer Disease. Continuum (Minneap Minn). 2024 Dec 01; 30(6):1614-1641.
PMID: 39620837

Clinical Manifestations.
Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e090906.
PMID: 39750399

Assessment of disease impact through health-related quality of life measurement in primary progressive aphasia.
Assessment of disease impact through health-related quality of life measurement in primary progressive aphasia. Alzheimers Dement (N Y). 2024 Oct-Dec; 10(4):e12499.
PMID: 39748847

Communication Bridge-2 randomized controlled trial: Recruitment and baseline features.
Communication Bridge-2 randomized controlled trial: Recruitment and baseline features. Alzheimers Dement. 2025 Jan; 21(1):e14168.
PMID: 39588869

An international core outcome set for primary progressive aphasia (COS-PPA): Consensus-based recommendations for communication interventions across research and clinical settings.
An international core outcome set for primary progressive aphasia (COS-PPA): Consensus-based recommendations for communication interventions across research and clinical settings. Alzheimers Dement. 2025 Jan; 21(1):e14362.
PMID: 39535361

Perceptions of brain health and aging among middle-aged latinos: A qualitative paper.
Perceptions of brain health and aging among middle-aged latinos: A qualitative paper. Patient Educ Couns. 2025 Jan; 130:108462.
PMID: 39413721

View All Publications